SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 117 filers reported holding SILVER STD RES INC in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | -90.9% | 434 | -89.5% | 0.00% | -88.9% |
| Q1 2017 | $44,000 | +2.3% | 4,134 | -13.9% | 0.04% | +100.0% |
| Q4 2016 | $43,000 | +152.9% | 4,800 | +242.9% | 0.02% | +63.6% |
| Q3 2016 | $17,000 | -5.6% | 1,400 | 0.0% | 0.01% | -15.4% |
| Q2 2016 | $18,000 | +100.0% | 1,400 | -12.5% | 0.01% | +116.7% |
| Q1 2016 | $9,000 | – | 1,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |